Document Detail


The role of terlipressin in pediatric septic shock: a review of the literature and personal experience.
MedLine Citation:
PMID:  17624234     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Vasopressin and its synthetic analog terlipressin are potent vasopressors that could be useful in vasodilatory septic shock. In septic adults, vasopressin-terlipressin have been shown to increase mean arterial pressure and to decrease the necessity for catecholamines. Moreover, low doses of vasopressin, or terlipressin, increase urine output and ameliorate oxygenation. Although pediatric septic shock is more often hypodynamic, both vasopressin and terlipressin have proved to be effective in restoring blood pressure or increasing the diuresis in this setting. The purpose of this review is to summarize the physiology of vasopressin and to report the available evidence for the use of vasopressin or terlipressin in pediatric septic shock in order to make best use in this population. We also report our experience with the continuous infusion of terlipressin in two pediatric patients who developed catecholamine refractory septic shock.
Authors:
P Papoff; M Mancuso; C S Barbara; C Moretti
Related Documents :
11956374 - Amplified cytokine response and lung injury by sequential hemorrhagic shock and abdomin...
2209154 - Effects of epinephrine on hemodynamics and oxygen metabolism in dopamine-resistant sept...
7444724 - The circulatory effects of an acute infusion of anaerobes in a rabbit model.
7700884 - Contribution of cardiac and arterial baroreceptors to enhanced vasopressin release duri...
8599894 - Influence of extreme head rotations on brainstem auditory evoked potentials (baep).
2614874 - Right ventricular mechanical and energetic properties.
Publication Detail:
Type:  Case Reports; Journal Article; Review    
Journal Detail:
Title:  International journal of immunopathology and pharmacology     Volume:  20     ISSN:  0394-6320     ISO Abbreviation:  Int J Immunopathol Pharmacol     Publication Date:    2007 Apr-Jun
Date Detail:
Created Date:  2007-07-12     Completed Date:  2007-09-19     Revised Date:  2009-11-19    
Medline Journal Info:
Nlm Unique ID:  8911335     Medline TA:  Int J Immunopathol Pharmacol     Country:  Italy    
Other Details:
Languages:  eng     Pagination:  213-21     Citation Subset:  IM    
Affiliation:
Department of Pediatrics, Pediatric Intensive Care Unit, University of Rome "La Sapienza", Italy. p.papoff@libero.it
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antihypertensive Agents / therapeutic use*
Child
Child, Preschool
Humans
Infant, Newborn
Lypressin / analogs & derivatives*,  physiology,  therapeutic use
Male
Shock, Septic / drug therapy*,  pathology
Vasoconstrictor Agents / therapeutic use*
Chemical
Reg. No./Substance:
0/Antihypertensive Agents; 0/Vasoconstrictor Agents; 14636-12-5/terlipressin; 50-57-7/Lypressin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Assessing treatment satisfaction in patients treated with pramlintide as an adjunct to insulin thera...
Next Document:  Interstitial lung disease in systemic sclerosis.